Subgroup | 30-day mortality | 90-day mortality | 1-year mortality | |||
---|---|---|---|---|---|---|
Hazard ratio (95% CI) | p value | Hazard ratio (95% CI) | p value | Hazard ratio (95% CI) | p value | |
Gender | ||||||
 Female (n = 1268) | 1.422 (1.063–1.901) | 0.018 | 1.362 (1.060–1.750) | 0.016 | 1.274 (1.030–1.577) | 0.026 |
 Male (n = 1208) | 1.108 (0.810–1.518) | 0.521 | 1.003 (0.767–1.311) | 0.984 | 1.059 (0.848–1.322) | 0.614 |
AF | ||||||
 No (n = 937) | 1.418 (0.977–2.058) | 0.066 | 1.497 (1.091–2.056) | 0.013 | 1.305 (0.997–1.708) | 0.052 |
 Yes (n = 1539) | 1.266 (0.977–1.641) | 0.075 | 1.123 (0.898–1.404) | 0.309 | 1.14 (0.945–1.374) | 0.171 |
COPD | ||||||
 No (n = 2203) | 1.313 (1.052–1.638) | 0.016 | 1.266 (1.047–1.530) | 0.015 | 1.263 (1.075–1.484) | 0.005 |
 Yes (n = 273) | 1.554 (0.683–3.539) | 0.293 | 1.171 (0.589–2.328) | 0.652 | 1.015 (0.608–1.693) | 0.955 |
IHD | ||||||
 No (n = 883) | 1.468 (1.064–2.024) | 0.019 | 1.231 (0.926–1.635) | 0.152 | 1.290 (1.014–1.642) | 0.038 |
 Yes (n = 1593) | 1.222 (0.920–1.622) | 0.166 | 1.222 (0.963–1.549) | 0.098 | 1.130 (0.926–1.379) | 0.228 |
Renal failure | ||||||
 No (n = 1048) | 1.797 (1.220–2.647) | 0.003 | 1.410 (1.010–1.968) | 0.043 | 1.316 (1.003–1.726) | 0.047 |
 Yes (n = 1428) | 1.212 (0.940–1.563) | 0.137 | 1.195 (0.961–1.486) | 0.108 | 1.188 (0.986–1.430) | 0.07 |